495 related articles for article (PubMed ID: 32203398)
1. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders.
Panza F; Lozupone M; Seripa D; Daniele A; Watling M; Giannelli G; Imbimbo BP
Nat Rev Neurol; 2020 Apr; 16(4):213-228. PubMed ID: 32203398
[TBL] [Abstract][Full Text] [Related]
2. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
3. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations.
Snowden JS; Adams J; Harris J; Thompson JC; Rollinson S; Richardson A; Jones M; Neary D; Mann DM; Pickering-Brown S
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):497-505. PubMed ID: 26473392
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
5. Frontotemporal dementia: implications for understanding Alzheimer disease.
Goedert M; Ghetti B; Spillantini MG
Cold Spring Harb Perspect Med; 2012 Feb; 2(2):a006254. PubMed ID: 22355793
[TBL] [Abstract][Full Text] [Related]
6. [Genetic architecture of amyotrophic lateral sclerosis and frontotemporal dementia : Overlap and differences].
Synofzik M; Otto M; Ludolph A; Weishaupt JH
Nervenarzt; 2017 Jul; 88(7):728-735. PubMed ID: 28573364
[TBL] [Abstract][Full Text] [Related]
7. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
Mackenzie IR; Neumann M
Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
[TBL] [Abstract][Full Text] [Related]
8. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells.
Lines G; Casey JM; Preza E; Wray S
Mol Cell Neurosci; 2020 Dec; 109():103553. PubMed ID: 32956830
[TBL] [Abstract][Full Text] [Related]
9. An update on genetic frontotemporal dementia.
Greaves CV; Rohrer JD
J Neurol; 2019 Aug; 266(8):2075-2086. PubMed ID: 31119452
[TBL] [Abstract][Full Text] [Related]
10. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
[TBL] [Abstract][Full Text] [Related]
11. Frontotemporal dementia.
Deleon J; Miller BL
Handb Clin Neurol; 2018; 148():409-430. PubMed ID: 29478591
[TBL] [Abstract][Full Text] [Related]
12. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review.
Seelaar H; Rohrer JD; Pijnenburg YA; Fox NC; van Swieten JC
J Neurol Neurosurg Psychiatry; 2011 May; 82(5):476-86. PubMed ID: 20971753
[TBL] [Abstract][Full Text] [Related]
13. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort.
Samra K; MacDougall AM; Bouzigues A; Bocchetta M; Cash DM; Greaves CV; Convery RS; van Swieten JC; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Laforce R; Graff C; Masellis M; Tartaglia MC; Rowe JB; Borroni B; Finger E; Synofzik M; Galimberti D; Vandenberghe R; de Mendonça A; Butler CR; Gerhard A; Ducharme S; Le Ber I; Tiraboschi P; Santana I; Pasquier F; Levin J; Otto M; Sorbi S; Rohrer JD; Russell LL;
J Neurol Sci; 2023 Aug; 451():120711. PubMed ID: 37348248
[TBL] [Abstract][Full Text] [Related]
14. Genetic screen in a large series of patients with primary progressive aphasia.
Ramos EM; Dokuru DR; Van Berlo V; Wojta K; Wang Q; Huang AY; Miller ZA; Karydas AM; Bigio EH; Rogalski E; Weintraub S; Rader B; Miller BL; Gorno-Tempini ML; Mesulam MM; Coppola G
Alzheimers Dement; 2019 Apr; 15(4):553-560. PubMed ID: 30599136
[TBL] [Abstract][Full Text] [Related]
15. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
16. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
[TBL] [Abstract][Full Text] [Related]
17. Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations.
Bouzigues A; Russell LL; Peakman G; Bocchetta M; Greaves CV; Convery RS; Todd E; Rowe JB; Borroni B; Galimberti D; Tiraboschi P; Masellis M; Tartaglia MC; Finger E; van Swieten JC; Seelaar H; Jiskoot L; Sorbi S; Butler CR; Graff C; Gerhard A; Langheinrich T; Laforce R; Sanchez-Valle R; de Mendonça A; Moreno F; Synofzik M; Vandenberghe R; Ducharme S; Le Ber I; Levin J; Danek A; Otto M; Pasquier F; Santana I; Rohrer JD;
J Neurol; 2022 Aug; 269(8):4322-4332. PubMed ID: 35348856
[TBL] [Abstract][Full Text] [Related]
18. Advances in understanding the molecular basis of frontotemporal dementia.
Rademakers R; Neumann M; Mackenzie IR
Nat Rev Neurol; 2012 Aug; 8(8):423-34. PubMed ID: 22732773
[TBL] [Abstract][Full Text] [Related]
19. Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.
Sellami L; Bocchetta M; Masellis M; Cash DM; Dick KM; van Swieten J; Borroni B; Galimberti D; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni G; Finger E; de Mendonça A; Sorbi S; Warren JD; Rohrer JD; Laforce R;
J Alzheimers Dis; 2018; 65(1):147-163. PubMed ID: 30010122
[TBL] [Abstract][Full Text] [Related]
20. Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia.
Fenoglio C; Serpente M; Visconte C; Arcaro M; Sorrentino F; D'Anca M; Arighi A; Rotondo E; Vimercati R; Rossi G; Scarpini E; Galimberti D
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
